Abstract
Week 26 results from the PaTH Forward Open-Label Extension Trial Support TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have